KPKendall C. Pitre

Kendall C. Pitre

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kendall C. Pitre has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • When Need Exceeds Support: Lower Medicaid Reimbursement for Cleft Orthodontia in High Pediatric Enrollment States

    by Ronald R. McCall, Ashlie Elver, John David West, Hannah Benton, Kendall C. Pitre, Ian C. Hoppe, Laura S. Humphries

    Objective: To analyze the association between Medicaid provider reimbursement for cleft lip and palate (CL/P) procedures and state-level economic factors. Design: Cross-sectional study of publicly available 2025 state Medicaid provider reimbursement rates associated with CL/P procedures. Statistical analysis compared provider reimbursement and demographic factors. Setting: National sample of Medicaid reimbursement fee schedules. Participants: Fifty U.S. states utilizing fee-for-service reimbursement. Main Outcome Measure(s): Reimbursement Rates for D8020 (Phase I: Limited Orthodontia, Transitional Dentition) and D8080 (Phase II: Comprehensive Orthodontia, Adolescent Dentition), CPT 42210 (Palatoplasty for Cleft Palate with Bone Graft), Pediatric Population of Medicaid and Children's Health Insurance Program. Results: D8080 reimbursement was negatively correlated with pediatric Medicaid enrollment ( r =  –0.375, p =  0.014). Multivariate linear regression predicted D8080 reimbursement, explaining 46.9% of variance (adjusted R 2 = 0.41). Higher reimbursement was associated with higher cost of living (β = 0.39, p =  0.007), poverty (β = 0.51, p <  0.001), and Medicaid expansion (β = 0.27, p =  0.041), but lower in states with greater pediatric enrollment (β = –0.53, p <  0.001). Conclusions: Medicaid provider reimbursement for comprehensive orthodontic treatment is independently associated with state socioeconomic characteristics. Reimbursement decreased with higher enrollment. This trend may further limit provider availability for low-income families with existing barriers in access to care. These findings suggest that Medicaid reimbursement may not adequately scale with pediatric beneficiary demand, potentially limiting access to multidisciplinary treatment.

  • Open Access

    Simultaneous Use of Intra-abdominal and Subcutaneous Tissue Expansion in Treatment of Giant Omphalocele: A Case Report

    by Kendall C. Pitre, Advait Praveen, Michael S. Lebhar, Michael W. Morris, Ian C. Hoppe

    Omphalocele is a congenital malformation of the abdominal wall consisting of a protrusion of the abdominal contents at the base of the umbilical cord. These defects often present significant anatomical and physiological challenges for reduction and closure, necessitating careful consideration of closure methods. Tissue expansion has emerged as an alternative technique to restore abdominal domain in omphalocele patients. The authors present a case of a 4-year-old female with a giant omphalocele, where both intra-abdominal and subcutaneous tissue expansion were utilized to restore abdominal domain and expand the soft tissue envelope for skin closure. The simultaneous use of intra-abdominal and subcutaneous tissue expansion represents a safe and effective strategy for achieving primary closure in patients with giant omphalocele.

  • Hospital Charges and Perioperative Outcomes of Spring-Assisted Cranioplasty vs Open Cranial Vault Remodeling for Sagittal Synostosis

    by Samantha D Morin, Adam B Fleming, Ronald R McCall, Kendall C Pitre, Henry H Taylor, Colton Fernstrum, Laura S Humphries, Ian C Hoppe

    Objective: To evaluate and compare perioperative outcomes and hospital charges between spring-assisted cranioplasty (SAC) and open cranial vault remodeling (OCVR) for single-suture craniosynostosis, with primary analysis focused on sagittal synostosis. Design: Retrospective cost analysis. Setting: Single tertiary academic center. Patients, Participants: Patients diagnosed with single-suture craniosynostosis who underwent surgical repair between 2012 and 2024. Interventions: Surgical repair via SAC or OCVR. Main Outcome Measure(s): Primary outcomes included operating room, anesthesia, intensive care unit (ICU), non-ICU, and total hospital charges. Secondary outcomes included hospital length of stay, estimated blood loss (EBL), transfusion volume, and need for subsequent craniofacial surgery. Results: Analysis was restricted to sagittal synostosis to ensure cohort comparability. SAC patients were younger at surgery (3.7 ± 1.1 vs. 16.2 ± 19.2 months; p < .001) and had reduced blood donor exposure (0.86 ± 0.45 vs. 1.24 ± 0.77; p = .019) and shorter ICU (1.14 ± 0.36 vs. 1.44 ± 0.66 days, p = .029) and hospital stay (3.3 ± 0.5 vs. 5.1 ± 0.5 days; p < .001) compared with OCVR. Total EBL was similar between groups (18.8 ± 4.0 vs. 19.1 ± 2.7 mL/kg; p = .92), although blood loss at spring removal was minimal. ICU charges were lower for SAC ($3846 ± 1695 vs. $4830 ± 2428; p = .045), while operating-room, anesthesia, and total hospital charges were comparable ( p > .05). Subsequent craniofacial surgery was less frequent following SAC (6.3% vs. 35.6%; p = .003), with all SAC reoperations representing planned staged procedures. Conclusions: In this institutional series of sagittal synostosis repairs, SAC was associated with lower ICU charges, fewer unique blood donor exposures, and fewer subsequent craniofacial procedures compared with OCVR. Although cumulative EBL and operative duration were similar, SAC redistributed blood loss across two shorter operations separated by several months, with minimal blood loss at removal and shorter hospitalization. These findings support SAC as a safe and efficient approach for appropriately selected infants with sagittal synostosis.


  • Sociodemographic Factors and Delays in Care for Patients Undergoing Treatment for Head and Neck Cancer in a Medically Underserved State

    by Kendall Pitre, Ron McCall, Mason Nodurft, Sara Islam, Ashlie Elver, Henry Taylor, Edward Facundus, Adam Fleming, John Phillips, Jesse Austin, et al.

    Timely surgical intervention for head and neck cancer (HNC) is critical to improving survival, particularly in advanced-stage disease requiring free-flap reconstruction. In medically underserved states, structural barriers such as rurality, socioeconomic disadvantage, and limited specialty availability can delay care. This study evaluates how race, insurance status, Social Vulnerability Index (SVI), and geographic distance affect delays in HNC surgical treatment in a state with the poorest national health outcomes and only one tertiary referral center. A retrospective cohort study was conducted at the University of Mississippi Medical Center, including all patients undergoing oncologic resection by oral and maxillofacial surgery and free-flap reconstruction by plastic surgery from January 2016 to July 2024. Demographics, tumor stage, insurance status, SVI, and driving distance were recorded. Care intervals were defined as the time from symptom onset to initial tertiary appointment (PreUMMC) and from initial appointment to surgery (PostUMMC). Of 180 patients (62.2% male, 70.6% White, 23.9% Black), 60% had government insurance and 22.5% resided in SVI quartile 4. Median PreUMMC delay was 115 days (interquartile range [IQR]: 61–225), which was over three times longer than the PostUMMC median of 28 days (IQR: 20–39; p < 0.001). PreUMMC delays were longest for SVI 4 patients (203.5 days, p = 0.029) and correlated with driving distance (ρ = 0.213, p = 0.004). Black patients were more likely to reside in high-SVI areas and present with advanced-stage tumors (pT4, 46.5 vs. 24.8%, p = 0.029). No significant sociodemographic differences were observed in PostUMMC timing. In Mississippi, disparities in HNC surgical timing occur predominantly before tertiary care access, reflecting the influence of geographic distance and social vulnerability. Once within the academic system, treatment timelines are equitable across groups. Addressing upstream barriers through targeted referral pathways, transportation solutions, and outreach to high-SVI communities is essential to improving timely surgical access.

  • Impact of Medicaid Expansion on State-Level Medicaid Reimbursement for Orthodontia in Patients With Cleft Lip and Palate: A Cost Analysis

    by Ronald Rae McCall, Ashlie A Elver, Kendall C Pitre, Ian C Hoppe, Laura S Humphries

    Objective: Examine state-level Medicaid reimbursement rates after Medicaid expansion for Phase I and II orthodontia relevant to patients with cleft lip and palate. Design: Cross-sectional study of publicly available 2024 state Medicaid reimbursement rates associated with Phase I and II orthodontia. One-Way ANOVA and independent t-tests compared regional and Medicaid expansion groups. Setting: National sample of Medicaid reimbursement fee schedules. Patients: Fifty US states, including DC, utilizing fee-for-service reimbursement for Medicaid enrollees. Main Outcome Measure(s): Reimbursement Rates for CPT Code D8020 (Phase I: Limited Orthodontia, Transitional Dentition) and D8080 (Phase II: Comprehensive Orthodontia, Adolescent Dentition) were compared between regions and by Medicaid expansion status. Results: Ten states did not adopt Medicaid Expansion (19.6%: AL, FL, GA, KS, MS, SC, TN, TX, WI, and WY). Coverage of Phase I care was low overall (58.5% of expanded and 55.6% of non-expanded states), with average reimbursement of $1080.13. More states offered Phase II coverage (87.8% of expanded and 77.8% of non-expanded states). Phase II reimbursement was higher in expansion states ($2596.73 ± $2252.59 vs non-expansion: $1266.78 ± $314.19; P = .001). The South trended toward higher reimbursement for Phase II ($3224.95; P = .093), followed by the West ($2902.88 ± 1327.40 vs $1413.26-$1699.10). Conclusions: Provider reimbursement influences access to orthodontia. Although Medicaid expansion aims to improve access for low-income families, gaps in orthodontic coverage persist. Despite higher Phase II reimbursement in Southern and expansion states, inadequate Phase I coverage and low reimbursement schedules limit provider participation, leaving low-income patients with clefts at risk for delayed or absent orthodontia and thus suboptimal outcomes.